CLINICAL SUPPLY MANUFACTURING ARTICLES

Point A To Point B GettyImages-1366401849 New DSCSA Compliance Blueprint Includes FDA & Industry Input

Pharmaceutical manufacturers, distributors, and pharmacies must all ensure they are ready for the Drug Supply Chain Security Act (DSCSA)'s full implementation starting on Nov. 27, 2023. The Partnership for DSCSA Governance, a public-private partnership, has published a blueprint compiling input from every sector, including FDA, industry, and solution providers.

CLINICAL SUPPLY MANUFACTURING VIDEOS

Expert speakers discuss current operational obstacles and explore strategic solutions to optimize a supply chain strategy in the years ahead.

Industry experts share insights to help you mitigate supply chain risk and accelerate access to novel cell and gene therapies.

Tony Sampognaro, Director, CMC Project Management, Stoke Therapeutics, recalls a rather harrowing experience involving a CMO and Clinical Operations failure to communicate.

If you are in the process of developing a complex or sensitive injectable drug, learn about containment solutions to mitigate your risks and help you get your drug to the patient faster.

CLINICAL SUPPLY MANUFACTURING RESOURCES